Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
MCF7
HR+
Luminal
Dichloroacetate
PDK
PDK
12657.176
uM
inf
inf
0.9410 0.9410 0.0000 0.0143
0.5190
1.0711
LY2
HR+
Luminal
PD184352
MEK
MAPK
12319.155
uM
inf
inf
0.7640 0.7640 0.0000 0.0144
0.5546
0.9333
LY2
HR+
Luminal
PD184352
MEK
MAPK
12319.155
uM
inf
inf
0.7640 0.7640 0.0000 0.0144
0.5546
0.9333
MDA-MB-453
TNBC
Luminal
Ribavirin
15398.211
uM
inf
inf
0.8982 0.8982 0.0000 0.0145
0.1417
1.0628
MDA-MB-361
HER2amp
Luminal
Baicalein
Lipoxygenase
Metabolism
10643.072
uM
139.8590
163.75380
0.1605 -0.6002 4.9999 0.0146
0.9776
0.6128
T47DKBLUC
Unknown
Unknown
JNK-IN-5A
JNK
JNK
12608.168
uM
inf
inf
0.9658 0.9658 0.0000 0.0146
0.0000
1.0486
MDA-MB-361
HER2amp
Luminal
Trametinib
MEK
MAPK
7505.05
uM
21.94740
24.13160
0.8214 -0.3035 4.9994 0.0147
0.6601
0.9037
SUM1315MO2
TNBC
Basal B
FTase Inhibitor I
Ftase
MAPK
10875.154
uM
32.91020
9.61220
0.4999 0.4988 4.8953 0.0149
0.9436
0.7163
AU565
HER2amp
Luminal
Dichloroacetate
PDK
PDK
13030.176
uM
inf
inf
0.8188 0.8188 0.0000 0.0150
0.5497
0.9892
AU565
HER2amp
Luminal
Ribavirin
15384.211
uM
inf
16.10260
0.6064 0.6043 4.5946 0.0152
0.9411
1.3162
MDA-MB-361
HER2amp
Luminal
FR180204
ERK1/2
MAPK
10643.137
uM
inf
6.50940
0.7332 0.7331 4.9998 0.0153
0.7892
0.6468
ZR75B
HR+
Luminal
PS-1145
IKK
NFKB
7555.065
uM
inf
inf
1.0207 1.0207 0.0000 0.0155
0.0000
1.7561
ZR75B
HR+
Luminal
Lapatinib
EGFR/HER2
ErbB
7555.098
uM
inf
inf
0.9380 0.9380 0.0000 0.0155
0.0592
1.6495
MCF7
HR+
Luminal
Cetuximab
EGFR
ErbB
9583.026
uM
inf
inf
0.9966 0.9966 0.0000 0.0156
-0.0344
1.2731
SK-BR-3
HER2amp
Luminal
FTase Inhibitor I
Ftase
MAPK
11851.154
uM
inf
inf
0.9971 0.9971 0.0000 0.0156
0.0000
1.1765
HCC1395
TNBC
Basal B
PS-1145
IKK
NFKB
7436.065
uM
inf
334.83990
0.7935 0.7935 5.0000 0.0156
0.8959
1.2177
MDA-MB-468
TNBC
Basal A
CPT-11
TOP1
TOP
7907.043
uM
inf
inf
0.8215 0.8215 0.0000 0.0156
0.4868
1.6330
184B5
NM
Basal
JNK-IN-5A
JNK
JNK
12566.168
uM
197.47390
224.21850
0.4789 -0.4434 4.9982 0.0157
0.9558
1.4366
HCC1954
HER2amp
Basal A
Baicalein
Lipoxygenase
Metabolism
7456.073
uM
128.7210
98.23510
0.3989 0.2947 3.2924 0.0159
0.9731
1.8650
HCC1187
TNBC
Basal A
AG1478
EGFR
ErbB
7811.044
uM
inf
inf
0.9811 0.9811 0.0000 0.0159
-0.0256
0.3073
HCC3153
TNBC
Basal A
Nutlin 3a
MDM2
MDM2
7466.066
uM
42.15690
43.02170
0.1633 -0.0345 3.2879 0.0160
0.9771
0.9420
MDA-MB-157
TNBC
Basal B
(Z)-4-Hydroxytamoxifen
ESR1
7878.016
uM
inf
15.01940
0.7927 0.8386 4.9792 0.0160
0.7114
1.4153
HCC1187
TNBC
Basal A
Pemetrexed
TYMS/DHFR/GARFT
TYMS
7432.095
uM
inf
inf
1.0222 1.0222 0.0000 0.0161
0.1254
0.8368
MDA-MB-361
HER2amp
Luminal
PD184352
MEK
MAPK
10643.146
uM
inf
inf
0.7735 0.7735 0.0000 0.0162
0.1132
0.6436
SUM149PT
TNBC
Basal B
Nilotinib
ABL
nRTK
10819.145
uM
inf
inf
0.9866 0.9866 0.0000 0.0162
0.0826
2.1971